Research of novel medical technologies using the self-assembling peptide, our core technology, has been progressing in multiple fields. PuraMatrix™, the first-generation self-assembling peptide, has the excellent ability to regenerate tissues with high affinity for cells. Moreover, PuraMatrix™ has been nanostructured with high biodegradability and biocompatibility; therefore, it has gained a high reputation as a drug delivery system (DDS).
Field Examples of Research Results
Regenerative Medicine Bone, myocardium, blood vessels, etc.
Cell Therapy ES cells, mesenchymal stem cells, liver cells, neurons, osteoblasts, chondrocytes, vascular endothelial cells, etc.
Surgical Treatment Wound healing, etc.
Drug Discovery Technology Use as a drug delivery system (DDS) for proteins and peptides (BMP, PDGF, IGF-1, etc.)
Research Reagents An exclusive distribution agreement with BD Biosciences (contract concluded)